Drug Shortage Report for AURO-APIXABAN
| Report ID | 241313 |
| Drug Identification Number | 02486806 |
| Brand name | AURO-APIXABAN |
| Common or Proper name | AURO-APIXABAN |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | APIXABAN |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 500's |
| ATC code | B01AF |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-10-28 |
| Estimated end date | 2024-12-30 |
| Actual end date | 2025-01-01 |
| Shortage status | Resolved |
| Updated date | 2025-01-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-01-03 | French | Compare |
| v4 | 2025-01-03 | English | Compare |
| v3 | 2024-10-29 | English | Compare |
| v2 | 2024-10-28 | French | Compare |
| v1 | 2024-10-28 | English | Compare |
Showing 1 to 5 of 5